Authors:
NEMUNAITIS J
BRUCE J
MONGIOVI D
WEINBERGER K
AZAD R
MONIA B
JOHNSTON J
GEARY R
KWOH J
DORR A
HOLMLUND J
Citation: J. Nemunaitis et al., PHASE-I TRIAL OF ISIS-2503, A 20-MER ANTISENSE PHOSPHOROTHIOATE OLIGONUCLEOTIDE AGAINST H-RAS, BY 14-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 324-324
Authors:
MANDIYAN S
SCHUMACHER C
CIOFFI C
SHARIF H
YURYEV A
LAPPE R
MONIA B
HANSON S
GOFF S
WENNOGLE L
Citation: S. Mandiyan et al., MOLECULAR AND CELLULAR CHARACTERIZATION OF BABOON C-RAF AS A TARGET FOR ANTIPROLIFERATIVE EFFECTS OF ANTISENSE OLIGONUCLEOTIDES, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(6), 1997, pp. 539-548
Citation: Df. Liao et al., PROTEIN-KINASE C-ZETA MEDIATES ANGIOTENSIN-II ACTIVATION OF ERK1 2 INVASCULAR SMOOTH-MUSCLE CELLS/, The Journal of biological chemistry, 272(10), 1997, pp. 6146-6150
Authors:
KENNEY CJ
WANCEWICZ E
CHIANG MY
MONIA B
BENNETT F
Citation: Cj. Kenney et al., PHOSPHOROTHIOATE OLIGONUCLEOTIDE EFFECTS ON INTERLEUKIN-1 EXPRESSION, The FASEB journal, 8(5), 1994, pp. 10000651-10000651